Tejara Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.92M	Buy	+166,191	New	+$4.24M	1.29%	27
2025 Q4	–	Sell	-520,503	Closed	-$9.81M	–	64
2025 Q3	$9.81M	Sell	520,503 -352,878	-40%	-$5.57M	5.38%	3
2025 Q2	$12.2M	Buy	873,381 +27,160	+3%	+$381K	5.68%	2
2025 Q1	$13.2M	Sell	846,221 -40,617	-5%	-$572K	6.52%	2
2024 Q4	$12.4M	Sell	886,838 -278,471	-24%	-$3.05M	8.1%	1
2024 Q3	$10.8M	Sell	1,165,309 -178,300	-13%	-$1.76M	5.17%	3
2024 Q2	$12.5M	Buy	1,343,609 +403,122	+43%	+$3.65M	4.55%	3
2024 Q1	$9.32M	Sell	940,487 -171,730	-15%	-$1.28M	3.45%	7
2023 Q4	$3.59M	Buy	1,112,217 +803,038	+260%	+$2.18M	1.5%	25
2023 Q3	$1.64M	Buy	309,179 +145,000	+88%	+$1.23M	0.93%	32
2023 Q2	$1.56M	Buy	164,179 +66,179	+68%	+$735K	0.77%	34
2023 Q1	$1.08M	Buy	98,000 +40,000	+69%	+$579K	0.55%	44
2022 Q4	$858K	Buy	+58,000	New	+$1.01M	0.5%	49